Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04520217 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Testing Use of Topical Imipramine in Reducing Ultraviolet B Induced Microvesicle Particle Release in Photosensitive Subjects

StatusRecruiting
PhasePhase 1
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary and study completion dates: Dec 2026 to Dec 1, 2026v10
  2. Re-verified, no change to tracked fieldsv9
  3. Primary and study completion dates: Dec 2022 to Dec 2026v8
  4. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Jun 2022 to Jun 6, 2022
    • Site details revised
    v7
  5. Start date: Mar 2022 to Jun 2022v6
Show 4 earlier versionsHide 4 earlier versions
  1. Lead sponsor: Wright State Physicians to Wright State Universityv5
  2. Start date: Dec 2021 to Mar 2022v4
  3. Primary completion date: Dec 2021 to Dec 2022
    • Start date: Aug 2021 to Dec 2021
    v3
  4. Start date: Dec 2020 to Aug 2021v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is three-fold. First, researchers will assess whether subjects who have clinically abnormal reactions to sunlight (photosensitivity) have increased levels of microvesicle particles (MVP) following ultraviolet B (UVB) treatment to localized area of skin. Second, researchers will assess if topical application of the medicine imipramine will block UVB-induced MVP release. Third, researchers will assess if the topical cream will block UVB-induced increased erythema reactions (reddening of the skin).
Trial Details
NCT Number NCT04520217
Lead Sponsor Wright State University
Conditions
(from sponsor)		 Photosensitivity, Microvesicle Particle
Related terms Photosensitivity Disorders
Enrollment 40 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov